We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTZG
1926
DELISTED
Nuveen Global Net Zero Transition ETF
NTZG
| $4.62M | ﹤0.01% |
195,705
+1,000
| +0.5% | +$25.9K |
|
1927
Upstart Holdings
UPST
$3.03B
| $4.61M | ﹤0.01% |
221,589
+34,441
| +18% | +$926K |
|
1928
Origin Bancorp
OBK
$1.66B
| $4.59M | ﹤0.01% |
119,366
-8,573
| -7% | -$356K |
|
1929
ZIM Integrated Shipping Services
ZIM
$3.24B
| $4.59M | ﹤0.01% |
+199,232
| New | +$8.23M |
|
1930
Lindsay Corp
LNN
$1.18B
| $4.59M | ﹤0.01% |
32,011
-621
| -2% | -$94K |
|
1931
PJT Partners
PJT
$4.38B
| $4.58M | ﹤0.01% |
68,515
-1,760
| -3% | -$123K |
|
1932
Revolution Medicines
RVMD
$44B
| $4.58M | ﹤0.01% |
232,104
+20,612
| +10% | +$453K |
|
1933
Virgin Galactic
SPCE
$398M
| $4.56M | ﹤0.01% |
48,378
-1,451
| -3% | -$186K |
|
1934
DHT Holdings
DHT
$3.02B
| $4.55M | ﹤0.01% |
602,147
+119,000
| +25% | +$891K |
|
|
DMC
1935
Del Monte Corp
DMC
$1.45B
| $4.55M | ﹤0.01% |
195,776
-3,300
| -2% | -$91.9K |
|
1936
Vaxcyte
PCVX
$8.64B
| $4.55M | ﹤0.01% |
189,512
+37,353
| +25% | +$947K |
|
|
BRSP
1937
BrightSpire Capital
BRSP
$648M
| $4.54M | ﹤0.01% |
719,865
+380,324
| +112% | +$3.14M |
|
|
TA
1938
DELISTED
TravelCenters of America LLC
TA
| $4.54M | ﹤0.01% |
84,185
-577
| -0.7% | -$28.7K |
|
1939
Liberty Broadband Class A
LBRDA
$5.16B
| $4.54M | ﹤0.01% |
60,785
-3,658
| -6% | -$387K |
|
1940
Healthcare Services Group
HCSG
$1.53B
| $4.53M | ﹤0.01% |
374,835
-13,557
| -3% | -$200K |
|
|
PFC
1941
DELISTED
Premier Financial Corp. Common Stock
PFC
| $4.52M | ﹤0.01% |
175,799
-85,226
| -33% | -$2.3M |
|
|
AY
1942
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $4.51M | ﹤0.01% |
171,499
+159,929
| +1,382% | +$5.29M |
|
1943
Zillow
ZG
$7.63B
| $4.49M | ﹤0.01% |
156,834
-3,604
| -2% | -$126K |
|
1944
NewMarket
NEU
$8.18B
| $4.48M | ﹤0.01% |
14,896
-1,784
| -11% | -$535K |
|
1945
FuelCell Energy
FCEL
$1.63B
| $4.47M | ﹤0.01% |
43,687
-1,735
| -4% | -$208K |
|
1946
Ligand Pharmaceuticals
LGND
$6.36B
| $4.47M | ﹤0.01% |
83,192
-2,280
| -3% | -$134K |
|
1947
Clarus
CLAR
$143M
| $4.47M | ﹤0.01% |
331,693
+116,910
| +54% | +$2.28M |
|
1948
Vicor
VICR
$10.2B
| $4.46M | ﹤0.01% |
75,437
-3,141
| -4% | -$207K |
|
1949
City Holding Co
CHCO
$2.04B
| $4.45M | ﹤0.01% |
50,192
-1,688
| -3% | -$144K |
|
|
SILK
1950
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $4.45M | ﹤0.01% |
98,892
-2,385
| -2% | -$103K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.